tiprankstipranks
Trending News
More News >
PolyPeptide Group AG (CH:PPGN)
:PPGN
Switzerland Market

PolyPeptide Group AG (PPGN) Financial Statements

Compare
1 Followers

PolyPeptide Group AG Financial Overview

PolyPeptide Group AG's market cap is currently CHF812.57M. The company's EPS TTM is CHF0.152; its P/E ratio is -43.40; PolyPeptide Group AG is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 391.87M€ 338.69M€ 320.37M€ 280.98M€ 282.13M
Gross Profit€ 64.32M€ 39.27M€ 4.77M€ 51.99M€ 99.70M
Operating Income€ 7.41M€ -7.36M€ -36.47M€ 12.61M€ 64.17M
EBITDA€ 44.42M€ 28.42M€ -22.15M€ 35.72M€ 83.35M
Net Income€ -21.31M€ -19.56M€ -51.44M€ 7.77M€ 47.26M
Balance Sheet
Cash & Short-Term Investments€ 74.53M€ 68.28M€ 95.71M€ 37.53M€ 136.30M
Total Assets€ 825.31M€ 756.58M€ 689.09M€ 575.78M€ 595.04M
Total Debt€ 130.46M€ 94.12M€ 113.66M€ 21.22M€ 18.00M
Net Debt€ 55.93M€ 25.84M€ 17.96M€ -16.31M€ -118.30M
Total Liabilities€ 484.98M€ 399.33M€ 307.86M€ 154.10M€ 173.87M
Stockholders' Equity€ 340.33M€ 357.24M€ 381.23M€ 421.68M€ 421.17M
Cash Flow
Free Cash Flow€ -30.44M€ 2.43M€ -20.25M€ -69.64M€ -16.61M
Operating Cash Flow€ 78.02M€ 89.40M€ 36.48M€ 5.46M€ 57.35M
Investing Cash Flow€ -112.44M€ -91.02M€ -59.51M€ -78.44M€ -80.84M
Financing Cash Flow€ 34.01M€ -25.32M€ 84.55M€ -26.87M€ 130.93M
Currency in EUR

PolyPeptide Group AG Earnings and Revenue History

PolyPeptide Group AG Debt to Assets

PolyPeptide Group AG Cash Flow

PolyPeptide Group AG Forecast EPS vs Actual EPS